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INTRODUCTION:
Pancreatic fibrosis is a common histopathological feature of alcoholic chronic pancreatitis. 1 Fibrogenesis involves a specific cell type in the pancreas, namely the pancreatic stellate cell (PSC). 2, 3 Recent studies have demonstrated that PSCs become activated [as indicated by proliferation, increased expression of the cytoskeletal protein alpha-smooth muscle actin (α-SMA) and synthesis of extracellular matrix proteins] when cultured on plastic or when exposed to ethanol and its oxidative metabolite acetaldehyde or to factors known to be upregulated during pancreatic injury such as proinflammatory cytokines, growth factors and oxidant stress. [2] [3] [4] PSCs in their quiescent (non-activated) state, store retinol as lipid droplets in their cytoplasm. Activation of PSCs is invariably associated with a loss of the retinol-containing droplets from their cytoplasm. 5, 6 Studies in other cell systems have established that retinol is a compound essential to normal cell biology. 7 In particular, the metabolites of retinol, alltrans retinoic acid (ATRA) and 9-cis retinoic acid (9-RA) have been shown to mediate a number of cellular functions including proliferation, differentiation and protein synthesis. 8 The metabolism of retinol has been best studied in the liver. It has been demonstrated in hepatic stellate cells (HSCs) that retinol enters the cell bound to cellular retinol binding protein (CRBP). 9 It is then either esterified to retinyl ester for storage, or converted to retinaldehyde by retinol dehydrogenase (ROLDH) and subsequently to retinoic acid by retinaldehyde dehydrogenase (RALDH). 10 Two forms of retinoic acid, ATRA and 9-RA serve as ligands for two families of nuclear receptors: retinoic acid receptors (RARα, β and γ) and retinoid X receptors (RXRα, β and γ). 8 The RARs bind to ATRA with high affinity, whereas 9-RA is a bifunctional ligand which can bind to and activate both RARs and RXRs. 11 Following ligand binding, these compounds interact with cis-acting DNA sequences called retinoic acid responsive elements (RAREs) in the promoter regions of target genes, thereby regulating gene expression. 8 It is of interest that studies with HSCs have demonstrated that upon exposure to activating factors, the levels of retinoic acid and the expression of their receptors is decreased. 12 Moreover, maintenance of the quiescent phenotype of HSCs has been shown to be dependent on adequate levels of retinoic acid and its receptors in the cells. 12 A recent study by Jaster et al 13 has reported decreased proliferation and collagen synthesis in PSCs upon exposure to ATRA. However, there has been no comprehensive study in the literature to date examining the effects of retinol and both its metabolites (ATRA and 9-RA) on PSC function.
A number of observations suggest a link between the metabolism of ethanol and retinol. Ethanol and its oxidative metabolite acetaldehyde are key activating factors of PSCs. 3 The oxidation of ethanol to acetaldehyde is mediated by the enzyme alcohol dehydrogenase (ADH). 10 Acetaldehyde is then further oxidised to acetic acid via aldehyde dehydrogenase (ALDH). 10 It has been established that the retinol metabolising enzymes ROLDH and RALDH belong to the same family of alcohol and acetaldehyde-metabolising dehydrogenases respectively. 10 Interestingly, studies have shown that rats chronically exposed to ethanol display significantly reduced retinoic acid levels in the liver.
14 This is thought to be due to competitive inhibition by ethanol of retinol metabolism by ROLDH and ADH, since these enzymes can utilise both ethanol and retinol as substrates. 15, 16 Thus, retinoic acid depletion may be an important mechanism by which ethanol promotes stellate cell activation.
In recent studies, we and others have identified the mitogen-activated protein kinase (MAPK) pathway as a major cell signalling pathway mediating ethanol-induced and growth factor-induced PSC activation. [17] [18] [19] MAPKs (which include extracellular-regulated kinases 1 and 2 [ERK1/2], N-terminal c-Jun kinase [JNK] and p38 kinase) play a major role in regulating protein synthesis in mammalian cells. 20, 21 MAPKs modulate the activity of a number of downstream transcription factors and protein kinases by phosphorylation, thereby controlling gene expression and cell behaviour. 21 Activation of MAPKs is a reversible process; they are inactivated by a group of protein phosphatases known as MAP kinase phosphatases (MKPs). 22 These are dual-specificity phosphatases which have been shown to exert their effect by dephosphorylating tyrosine and threonine residues on MAPKs thereby leading to their inactivation. 22 MAPK phosphatase-1 (MKP-1), a member of the MKP family, has recently been demonstrated to inactivate all 3 classes of MAPKs. 23, 24 It is interesting to note that recent studies have shown that MKP-1 expression is increased upon exposure to retinoic acid thereby resulting in a decrease in MAPK activity. 25 However, whether retinol influences the MAPK signalling pathway or MKP-1 expression in stellate cells (whether from the pancreas or liver) is not known.
Therefore, the aims of this study were to: i) examine the effect of retinol and its metabolites ATRA and 9-RA on PSC activation, ii) determine whether retinol influences MAPK signalling and MKP-1 expression in PSCs, and iii) assess the influence of retinol on ethanol-treated PSCs.
METHODS:
Cell culture reagents, protease type XIV, all-trans retinol, all-trans retinoic acid, 9-cis retinoic acid were purchased from the Sigma Chemical Company (St Louis, MO, USA). Primers for ROLDH II, RARα, RXRα and RXRβ were obtained from Sigma Genosys Australia Pty Ltd. Sources of antibodies were as follows: α-SMA, fibronectin and lamininSigma; phospho-ERK1/2 and total ERK1/2, total p38 kinase and total JNK -Cell Signaling Technology (Beverly, MA, USA); phospho-p38 kinase and phospho-JNK -Promega (Sydney, Australia); MKP-1, RARα, RXRα and RXRβ -Santa Cruz Biotechnology (Santa Cruz, CA, USA); collagen type I -Rockland Immunochemicals (Gilbertsville, PA, USA); secondary goat anti-rabbit antibody -DAKO (Sydney, Australia).
Isolation and culture of PSCs
Rat pancreatic stellate cells were isolated by density gradient centrifugation as detailed previously. 5 Culture-activated PSCs (passage 1-3) were exposed to retinol (10µM), ATRA (10µM) or 9-RA (10µM) for varying periods of time. Medium was changed every 48 hours. All manipulations were performed in subdued light. Cells incubated with culture medium with an equivalent amount of vehicle -DMSO 0.1% (for ATRA and 9-RA experiments) or DMSO 0.025% + 8mM ethanol (for retinol experiments) served as controls. Cell viability was assessed by trypan blue exclusion studies.
Treatment of PSCs with ethanol and retinol
To determine the effect of retinol on PSCs treated with ethanol, cells were incubated with 10µM retinol in the presence or absence of 50mM ethanol for 5 days. Medium was changed every 24 hours. At the end of the incubation period cell lysates were collected and expression of α-SMA, collagen I, fibronectin and laminin was assessed by western blotting. Cell viability was assessed as described earlier.
Assessment of PSC Function

Cell Proliferation
PSC proliferation was assessed by measuring the incorporation of [
3 H] thymidine into cellular DNA as previously described. 28 In addition, cell counts were performed using a haemocytometer. Results are expressed as a percentage of control.
α-Smooth muscle actin and extracellular matrix protein expression
Levels of α-SMA, collagen I, fibronectin and laminin in PSCs were determined by western blotting of cell lysates as detailed previously, using a monoclonal mouse anti-α-SMA (1:200); 3 , or polyclonal rabbit anti-collagen I (1:1000), anti-fibronectin (1:1000) and antilaminin (1:1000) antibodies. 29, 30 A goat anti-mouse antibody (1:2000) or a goat anti-rabbit antibody (1:2000) was used as the secondary antibody. Expression of α-SMA, collagen I, fibronectin and laminin was detected by the enhanced chemiluminescence (ECL) technique using the Amersham enhanced ECL kit and quantified using densitometry (BioRad GelDoc Image One software).
Detection of MAPK activation
ERK1/2, p38 kinase and JNK activation in culture-activated PSCs exposed to retinol (10µM), ATRA (10µM) or 9-RA (10µM) for 4, 24 and 48 hours was assessed by western blotting of cell lysate proteins, as described previously. 17, 28 To confirm that total MAPK levels were unchanged by the treatments, aliquots of the above cell lysates were subjected to western blotting analysis using rabbit polyclonal antibodies against ERK1/2, p38 kinase or JNK (1:1000), which recognise both the phosphorylated and non-phosphorylated forms of the enzymes; the blots were then analysed by densitometry.
RAR and RXR expression in PSCs treated with 10µM ATRA or 10µM 9-RA for 4, 24 and 48 hours was assessed by western blotting using polyclonal rabbit antibodies against RARα, RXRα or RXRβ (1:200).
Detection of MKP-1 Expression
MKP-1 expression in PSCs incubated with retinol, ATRA or 9-RA for 3, 6, and 24 hours was assessed by western blotting using a polyclonal rabbit anti-MKP-1 antibody (1:1000). To determine the role of MKP-1 in regulating the action of ATRA on MAPKs, we examined whether any observed inhibition of MAPKs by ATRA could be prevented by the protein phosphatase inhibitor sodium orthovanadate, a potent inhibitor of protein tyrosine phosphatases, which include MKP-1. 31, 32 The influence of this inhibitor on PSC function (cell proliferation and ECM protein expression) was also assessed. PSCs were treated with 10µM ATRA in the presence or absence of 1µM sodium orthovanadate (SV) for 48 hours. At the end of the incubation period, cell counts were performed using a haemocytometer and cell lysates were collected for assessment of MAPK activation and ECM protein expression by western blotting as described above.
Treatment of freshly isolated PSCs with retinol
To determine whether retinol could prevent/retard the transition of freshly isolated (quiescent) PSCs to their activated phenotype, freshly isolated cells were incubated in (IMDM) supplemented with 10% fetal bovine serum in the presence or absence of 10µM of retinol for 5 days. Medium was changed every 24 hours. At the end of the incubation period cell lysates were collected and expression of α-SMA and fibronectin was assessed as described above.
STATISTICS
Results are expressed as mean ± standard error; n represents the number of individual PSC preparations. Data were analysed using repeated measures analysis of variance (ANOVA). 33 Fisher's protected least significant difference (PLSD) was used for comparison of individual groups provided the F-test was significant. 33, 34 Analyses were performed using the Statview II  statistical software package.
RESULTS
Expression of retinol dehydrogenase II and retinoic acid receptors in PSCs
Using RT-PCR, retinol dehydrogenase II (ROLDH II), RARα, RXRα and RXRβ expression was observed in PSCs ( Fig 1A and 1B , n = 3 separate cell preparations). The PCR products were 398bp, 195bp, 165bp and 175bp respectively, in agreement with previous reports.
26, 27
Retinol and its metabolites ATRA and 9-RA induce PSC quiescence A) Cell proliferation Retinol, ATRA and 9-RA reduced the proliferation of culture-activated PSCs (n = 4 separate cell preparations) as assessed by thymidine incorporation into cellular DNA as well as by direct cell counts. There was a significant reduction after 72 hours of incubation with retinol and this effect was sustained over 96 hours (Fig 2) . Proliferation was also significantly reduced in the presence of ATRA and 9-RA (Fig 2) . Notably, this reduction was observed at an earlier time point (48 hours) than that produced by retinol and this effect was sustained over 96 hours. We confirmed that the observed reduction in PSC proliferation was not due to cytotoxicity of retinol, ATRA or 9-RA as evaluated by phase contrast microscopy and trypan blue exclusion studies (results not shown).
B) α-SMA expression
Quiescence of PSCs after incubation with retinol (n = 3 separate cell preparations) was also demonstrated by significantly reduced α-SMA expression after 72 hours, an effect that was sustained over 96 hours (Fig 3) . Similar results were obtained with ATRA and 9-RA (Fig  3) . ATRA was also associated with reduced α-SMA expression at the earlier time point of 48 hours.
C) Extracellular matrix protein expression ECM protein expression was significantly reduced in PSCs exposed to retinol or its metabolites (n = 3 separate cell preparations; Fig 4A, B and C) . After 48 hours of incubation, retinol significantly decreased collagen I, fibronectin and laminin expression and this effect was sustained over 72 hours. Similar results were obtained for ATRA and 9-RA.
Retinol and its metabolites ATRA and 9-RA influence MAPK activation in PSCs A) ERK 1/2 activation
Incubation of PSCs with retinol (n = 4 separate cell preparations ) caused a significant decrease in ERK1/2 activation at 4 hours; this decrease was sustained over 48 hours (Fig 5) . Similarly, ERK1/2 activation was reduced in the presence of ATRA and 9-RA (Fig 5) . 
B) p38 kinase activation
Retinol significantly decreased p38 kinase activation after 48 hours of incubation (n = 4 separate cell preparations; Fig 6) . Both ATRA and 9-RA also significantly reduced p38 kinase activation. However, this reduction was observed at the earlier time points of 4 and 24 hours and was sustained over 48 hours (Fig 6 
C) JNK activation
In contrast to the effect on ERK and p38 kinase activation, incubation of PSCs with retinol or 9-RA had no effect on JNK 2 (p54) activation (n = 4 separate cell preparations; Fig 7) . However, ATRA significantly decreased JNK 2 (p54) activation after 4 hours and this decrease was sustained over 48 hours (Fig 7) . Effect of retinol, ATRA and 9-RA on MKP-1 expression
ATRA significantly increased MKP-1 expression in PSCs (n = 3 separate cell preparations) at 6 hours and this increase was sustained over 24 hours (Fig 8) . In contrast, retinol and 9-RA had no effect on MKP-1 expression (results not shown).
Effect of the protein phosphatase inhibitor sodium orthovanadate on MAPK expression, cell proliferation and ECM protein expression in ATRA-treated PSCs To confirm whether MKP-1 plays a role in mediating the effect of ATRA on MAPK activation in PSCs, cells were treated with the protein phosphatase inhibitor sodium orthovanadate (n = 3 separate cell preparations). As shown in Figure 9 , the ATRA-induced decrease in activation of ERK1/2, p38 kinase and JNK 2 was completely prevented in the presence of sodium orthovanadate (SV), suggesting that MKP-1 may mediate the ATRAinduced inhibition of MAPK activation. SV treatment of PSCs also prevented the ATRAinduced decrease in i) PSC proliferation (data expressed as % of control mean ± SEM : Control 100, ATRA 44.74 ± 8.72*, SV 85.35 ± 16.5, ATRA + SV 98.03 ± 26.8; *p<0.01 ATRA vs control) and ii) collagen I, fibronectin and laminin expression (Fig 10) , further supporting the concept that the effects of ATRA on PSC function may be mediated via the MAPK pathway. Trypan blue exclusion studies confirmed cell viability in the presence of SV (results not shown).
Effect of ATRA and 9-RA on RAR and RXR protein expression After 4 hours of incubation, both ATRA and 9-RA significantly increased RARα protein expression in PSCs (n = 3 separate cell preparations) and this effect was sustained over 24 and 48 hours (Fig 11A) . 9-RA also increased the expression of RXRα and RXRβ at 4, 24 and 48 hours of incubation (Fig 11B) .
Effect of retinol on ethanol-induced PSC activation
A)
α -SMA expression In order to determine whether retinol supplementation could prevent ethanol-induced PSC activation, α-SMA expression was assessed (n = 3 separate cell preparations, Fig 12) . As expected, ethanol alone significantly increased α -SMA expression confirming our previously published results. 3, 17 Retinol alone significantly reduced α -SMA expression confirming our results described in Fig 3. Importantly, retinol also significantly reduced α -SMA expression in PSCs treated with ethanol. Of particular interest was the finding that in the presence of ethanol, retinol was unable to fully exert its inhibitory effect when compared to retinol alone (compare Rol with Rol + E50, Fig 12) .
B) Extracellular matrix protein expression
As illustrated in Fig 13, retinol significantly inhibited the expression of all 3 ECM proteins in PSCs (n = 3 separate cell preparations) and also prevented the ethanol-induced increase of collagen I, fibronectin and laminin expression in the cells. Interestingly, as with α-SMA expression, retinol was unable to fully exert its inhibitory effect on collagen I and laminin expression in the presence of ethanol, when compared to retinol alone.
Effect of retinol on freshly isolated PSCs
Incubation of freshly isolated PSCs with retinol for 5 days significantly decreased the expression of both α-SMA and fibronectin in the cells when compared to controls (Fig 14 A  and B) .
DISCUSSION
This study provides novel data demonstrating that vitamin A (retinol) induces quiescence in both freshly isolated and culture activated PSCs. We have also shown that the metabolites of vitamin A (ATRA and 9-RA) inhibit the activation of culture-activated PSCs. Notably, we have found that the above effects are associated with a significant decrease in the activation of all 3 classes of MAPKs, suggesting that vitamin A-induced quiescence is mediated via the MAPK pathway. Another novel finding of this study (of relevance to alcohol-induced fibrosis) is the prevention of ethanol-induced PSC activation by retinol. To the best of our knowledge, this aspect has not been previously studied in pancreatic or hepatic stellate cells.
The present study has also provided evidence indicating that PSCs possess the ability to convert retinol into its active metabolites. We have shown that cultured PSCs express the enzyme retinol dehydrogenase II (ROLDH II), an enzyme which is essential for the conversion of cellular retinol to retinoic acid. Our findings also suggest the presence of a functional retinoic acid signalling pathway in PSCs. We have identified mRNA for RAR and RXRs in the cells and moreover, have found that the expression of RAR and RXR proteins is induced by their ligands ATRA and 9-RA. The observed induction of receptor protein expression by their ligands in PSCs concurs with a previous report in cardiomyocytes, showing that both RAR and RXR are transcriptionally activated by ATRA and 9-RA. 35 The signalling pathways responsible for regulating PSC activation have been the focus of much interest in recent years, since therapeutic targeting of relevant signalling molecules may enable inhibition of PSC activation and prevention of fibrogenesis. Studies by our group and others have demonstrated that all 3 classes (ERK1/2, JNK and p38 kinase) of the MAPK pathway play an important role in mediating PSC activation upon exposure to profibrogenic factors. [17] [18] [19] The ERK1/2 pathway has been shown to mediate PSC proliferation by increasing the activity of the transcription factor AP-1. 19 Recently, our group and others have shown that the p38 kinase pathway plays a major role in mediating α -SMA expression in culture-activated and ethanol treated PSCs. 17, 36 Masamune et al 18, 37 reported that both p38 kinase and JNK play an important role in mediating ECM protein synthesis in PSCs. Given the above, it would be reasonable to speculate that inhibition of PSC activation by vitamin A may be mediated by the inhibition of the MAPK pathway. The results of our study support this concept. We have demonstrated for the first time that retinol, ATRA and 9-RA significantly decrease the activation of ERK1/2 and p38 kinase in culture-activated PSCs after 4 hours of incubation and this decrease was sustained over 48 hours. In addition, ATRA (but not retinol or 9-RA) significantly decreased JNK 2 (p54) activation at 4, 24 and 48 hours. Our results with ATRA concur with those reported in human bronchial cells and hepatocytes. 25, 38 Both ERK1/2 and JNK MAPKs are known to regulate the activity of the transcription factor AP-1, which in turn is known to be an essential factor for the regulation of cell proliferation. 21 Upon activation, AP-1 binds to a DNA sequence motif in target genes, thereby regulating their expression. 39 A number of studies in other cell types have shown that increased AP-1 activity is essential in regulating cell proliferation (see review). 40 It is of interest to note that upon exposure to vitamin A, AP-1 activity is decreased in a number of different cell types, and this is thought to be one of the mechanisms whereby vitamin A inhibits cell proliferation. 41 The mechanisms of MAPK inhibition (inactivation) by vitamin A are not yet determined. While activation of MAPK depends on phosphorylation of its tyrosine and threonine residues by upstream kinases, recent studies indicate that inactivation of MAPK is secondary to dephosphorylation via MAP kinase phosphatases (MKPs). 22 MKP-1 has been group.bmj.com on November 8, 2017 -Published by http://gut.bmj.com/ Downloaded from shown to inactivate all 3 classes of MAPKs. 23, 24 Interestingly, studies in other cell types have reported that treatment with vitamin A increases the expression of MKP-1 which in turn results in a decrease in MAPK activity. 25, 31, 42 The current study has demonstrated that ATRA (but not retinol or 9-RA) induces the expression of MKP-1 in PSCs. This induction is evident after 6 hours of incubation and is sustained over 24 hours. We have further demonstrated that the protein phosphatase inhibitor sodium orthovanadate (known to inhibit phosphatases such as MKP-1) prevents the inhibition of MAPK activation in PSCs treated with ATRA. These findings support the concept that an increase in MKP-1 activity may play a role in the observed decrease in MAPK activation in PSCs exposed to ATRA. The mechanisms responsible for the retinol-and 9-RA-induced decrease in MAPK activation are unclear (given that these compounds did not increase MKP-1 activity in PSCs). It is possible that these compounds induce the activity of other phosphatases of the MAPK phosphatase family, as has been reported by Palm-Leis et al 35 in cardiomyocytes.
It is now generally accepted that ethanol-induced PSC activation plays a major role in alcoholic pancreatic fibrosis. 3 In view of our findings that retinol induces quiescence of PSCs in culture, we examined the effect of retinol on ethanol-treated PSCs. Our results have shown that retinol prevents ethanol-induced PSC activation as evidenced by a significant decrease in α -SMA expression, and more importantly, a significant decrease in the expression of the ECM proteins collagen I, fibronectin and laminin which are major components of fibrous tissue. In the course of these studies, an interesting observation was made with respect to the effect of retinol on PSC activation in the presence and absence of ethanol. In the presence of ethanol, retinol was found to be unable to exert its full inhibitory effect on α -SMA, collagen I, and laminin expression when compared to retinol alone (see Fig 12 Rol vs Rol+E50 for α -SMA expression and Fig 13 Rol vs Rol+E50 for collagen I and laminin expression). One possible explanation for this could be the competitive inhibition of retinol metabolism by ethanol, since the enzymes ROLDH and ADH can use both retinol and ethanol as substrates. 26, 43 There is evidence for the presence of both these enzymes in PSCs. The current study has demonstrated the expression of mRNA for ROLDH in PSCs, while previous studies by our group have demonstrated alcohol dehydrogenase (ADH) enzyme activity (inducible after exposure to ethanol) in PSCs. 3 A decrease in retinol metabolism in ethanol-treated PSCs would lead to lower retinoic acid levels in these cells when compared with PSCs treated with retinol alone.
In conclusion, this study is the first to demonstrate that vitamin A and/or its metabolites ATRA and 9-RA induce quiescence in both freshly isolated and culture-activated PSCs. Induction of PSC quiescence is associated with a decrease in the activation of all 3 classes of MAPKs. Furthermore, we have demonstrated that retinol supplementation prevents ethanol-induced activation of PSCs. These findings suggest that vitamin A may be a potentially useful antifibrotic agent in chronic pancreatitis via its ability to inhibit PSC activation and consequently reduce their synthesis of ECM proteins. thymidine incorporation studies and (B) cell count data demonstrating that incubation of PSCs with retinol (Rol) decreased PSC proliferation significantly when compared to controls after 72 hours and that this effect was sustained over 96 hours. ATRA and 9-RA also significantly decreased PSC proliferation after 48 hours when compared to controls and this effect was sustained over 96 hours (n = 3 separate cell preparations; **p < 0.01, *p < 0.001). Densitometry analysis of all western blots showing a significant decrease in p38 kinase activation in PSCs treated with Rol after 48 hours compared to controls. Treatment with ATRA or 9-RA also resulted in a significant decrease in p38 kinase activation after 4 hours and was sustained after 48 hours compared to controls (n = 4 separate cell preparations; *p < 0.01, **p < 0.02, # p < 0.03). Rol, ATRA or 9-RA treatment had no significant effect on total p38 kinase levels in PSCs. showing a significant decrease in JNK 2 (p54) activation after 4, 24 and 48 hours treatment with ATRA compared to controls (n = 3 separate cell preparations; *p < 0.01, **p < 0.005). Both Rol and 9-RA had no effect on JNK 2 (p54) activation. Total JNK 2 levels were unchanged by Rol, ATRA or 9-RA treatment. blots showing a significant increase in MKP-1 expression after 6 hours of treatment with ATRA; and this effect was sustained over 24 hours compared to controls (n = 3 separate cell preparations; *p < 0.005). Both Rol and 9-RA had no effect on MKP-1 expression (data not shown). 
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